The E.W. Scripps Company filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing financial results, balance sheet changes, and a new Rule 10b5-1 trading arrangement by a company director.

Key Highlights

  • Director trading plan: Charles L. Barmonde, a director of the Company, adopted a Rule 10b5-1 trading arrangement providing for the periodic sale of up to 40,000 shares of common stock between September 8, 2026 and September 8, 2027.
  • Total assets declined: Total assets were $3,637,616 thousand as of September 30, 2026, compared to $5,008,628 thousand as of December 31, 2025.
  • Accumulated deficit widened: The accumulated deficit stood at $1,692,262 thousand as of September 30, 2026, versus $576,881 thousand as of December 31, 2025.
  • Goodwill decreased significantly: Goodwill was reported at $931,534 thousand as of September 30, 2026, down from $1,918,334 thousand at December 31, 2025.
  • Cash increased: Cash and cash equivalents were $83,390 thousand at September 30, 2026, up from $27,923 thousand at December 31, 2025.
  • Shares outstanding: As of September 30, 2026, there were 81,085,753 Class A Common shares and 11,932,722 Common Voting shares outstanding.
  • No unregistered equity sales or senior securities defaults: The filing states there were no sales of unregistered equity securities and no defaults upon senior securities during the quarter ended September 30, 2026.

E.W. Scripps Q3 2026: Balance Sheet Shifts and Director Trading Plan

The E.W. Scripps Company (NASDAQ:SSP) filed its Form 10-Q for the quarter ended September 30, 2026, reporting notable changes to its balance sheet relative to year-end 2025. According to the filing, total assets fell to $3,637,616 thousand from $5,008,628 thousand at December 31, 2025. The company attributed part of this change to shifts in goodwill, which declined from $1,918,334 thousand to $931,534 thousand, and the elimination of assets held for sale, which had been $102,933 thousand at year-end 2025 and were zero at the close of the third quarter.

The accumulated deficit widened materially, from $576,881 thousand at December 31, 2025 to $1,692,262 thousand at September 30, 2026, according to the condensed consolidated balance sheets included in the filing. Total equity fell to $142,627 thousand from $1,246,092 thousand over the same period. Long-term debt (less current portion) was reported at $2,457,441 thousand, down from $2,585,534 thousand at year-end. The Series A Preferred Stock, with 6,000 shares issued and outstanding, carried a redemption value of $799,260 thousand at September 30, 2026, compared to $749,587 thousand at December 31, 2025, as stated in the filing.

In Part II, Item 5, the filing disclosed that director Charles L. Barmonde adopted a Rule 10b5-1 trading arrangement covering the periodic sale of up to 40,000 shares of common stock, with the plan running from September 8, 2026 through September 8, 2027. The filing stated that no other directors or officers adopted, modified, or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the quarter. The company also disclosed involvement in ordinary-course litigation and regulatory proceedings, including defamation actions and broadcast license renewal proceedings, none of which is "expected to result in material loss," according to the filing.

What Was Disclosed

The E.W. Scripps Company disclosed quarterly financial statements for the period ended September 30, 2026, showing a significant decline in total assets and a widening accumulated deficit, alongside a new director 10b5-1 trading plan for up to 40,000 shares.